Target intelligence / Profile preview

Feline infectious peritonitis virus 3C-like protease (3CLpro)

Target
3CLpro
Molecular classification
Enzyme, Cysteine protease, Hydrolase
01

Overview

The Feline infectious peritonitis virus 3C-like protease (3CLpro), also known as the main protease (Mpro) or NSP5, is a critical cysteine protease required for the maturation of the feline coronavirus (FCoV), the causative agent of Feline Infectious Peritonitis (FIP) (Kim et al., 2016, PLOS Pathogens). This enzyme is responsible for the proteolytic processing of the large viral polyproteins, pp1a and pp1ab, at multiple conserved sites to release functional non-structural proteins essential for viral replication and transcription (Pedersen et al., 2018, Journal of Feline Medicine and Surgery). Because 3CLpro possesses a unique substrate specificity that is not found in host cell proteases, it serves as a highly selective and effective target for antiviral therapy (UniProt P0C6V2). Small molecule inhibitors like GC376 bind to the catalytic cysteine residue of the enzyme, effectively blocking its activity and leading to significant clinical recovery in cats with both effusive and non-effusive FIP (Kim et al., 2016). Recent studies have also demonstrated that 3CLpro inhibitors developed for human coronaviruses, such as Nirmatrelvir, show potent cross-species activity against the FIPV enzyme, facilitating new avenues for veterinary treatment (Cook et al., 2022, Viruses).

Other names
Main proteaseMproNSP53C-like cysteine proteaseFIPV 3CLproC30 endopeptidase
02

Mechanism of action

Inhibition of the 3C-like protease prevents the proteolytic cleavage of the viral polyproteins pp1a and pp1ab into functional non-structural proteins, thereby halting the assembly of the viral replication-transcription complex and stopping viral replication.

03

Biological functions

Viral polyprotein processingViral replicationProteolysis
04

Disease associations

Feline infectious peritonitisInfection
05

Safety considerations

Injection site reactions (stinging or local dermatitis)Potential for viral resistance mutations in the NSP5 geneTransient increases in liver enzymesLack of long-term safety data in pediatric feline populations
06

Interacting drugs

GC376

1 more in the full profile.

07

Biomarkers

Feline coronavirus (FCoV) RNA viral loadSerum albumin-to-globulin (A:G) ratioAlpha-1-acid glycoprotein (AGP) levelsResolution of abdominal or thoracic effusion

Beyond the preview

Go deeper on Feline infectious peritonitis virus 3C-like protease (3CLpro).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Feline infectious peritonitis virus 3C-like protease (3CLpro).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call